Jardiance Empagliflozin (25mg) Tablet – Global Exporter, Supplier & Worldwide Delivery | GlobMedIndia
Jardiance Empagliflozin (25mg) Tablet
Jardiance Empagliflozin (25mg) Tablet is an oral anti-diabetic medicine used in the management of Type 2 Diabetes Mellitus. It belongs to the SGLT2 (sodium-glucose co-transporter 2) inhibitor class and works by helping the kidneys remove excess glucose through urine, thereby lowering blood sugar levels. It is also widely used for reducing the risk of cardiovascular events and supporting kidney health in diabetic patients under medical supervision.
Contact Details
WhatsApp: +91 9730316395
Phone: +91 9730316395
Email: info@globmedindia.com
Website: https://globmedsindia.com
GlobMedIndia – The Medicine Exporter is a trusted international pharmaceutical supplier providing fast, safe, and secure worldwide doorstep delivery of medicines. We specialize in exporting life-saving and critical care medicines, including anti-cancer drugs, targeted therapies, injectables, and specialty pharmaceuticals across global markets. We ensure authentic, high-quality, and temperature-controlled pharmaceutical delivery directly from India to patients, hospitals, and healthcare providers worldwide.
What is Jardiance Empagliflozin (25mg) Tablet?
Empagliflozin (commonly known by the brand Jardiance) is an SGLT2 inhibitor that lowers blood glucose by increasing urinary glucose excretion. It is widely prescribed for Type 2 Diabetes Mellitus and is also used in patients with heart failure and chronic kidney disease to improve clinical outcomes.
It may be used alone or in combination with other anti-diabetic medicines such as metformin, insulin, or DPP-4 inhibitors.
Therapeutic Uses of Jardiance Empagliflozin (25mg) Tablet
Type 2 Diabetes Mellitus management
Blood sugar level control
Cardiovascular risk reduction in diabetic patients
Heart failure management support
Chronic kidney disease supportive therapy
Combination anti-diabetic therapy
Long-term glycemic control
Benefits of Jardiance Empagliflozin (25mg) Tablet
Helps reduce blood glucose levels effectively
Promotes glucose elimination through urine
Supports heart health in diabetic patients
Helps protect kidney function
May support weight reduction
Low risk of hypoglycemia when used appropriately
Clinically proven SGLT2 inhibitor therapy
Why Choose GlobMedIndia?
GlobMedIndia is a leading exporter, wholesaler, retailer, and supplier of pharmaceutical medicines, specialty drugs, and critical care products worldwide.
Genuine and quality-assured medicines
Competitive international pricing
Fast global pharmaceutical export services
Secure packaging and temperature-controlled logistics
Bulk supply for hospitals and distributors
Regulatory documentation support
Reliable worldwide delivery network
Trusted global pharmaceutical sourcing partner
United States
Jardiance Empagliflozin USA, diabetes medicine California, Jardiance New York supplier, SGLT2 inhibitor Texas, empagliflozin Florida pharmacy, diabetes tablets USA wholesale
United Kingdom & Europe
Jardiance UK, empagliflozin London pharmacy, diabetes medicine Manchester, SGLT2 inhibitor Europe supplier, Jardiance Germany, empagliflozin France
Middle East
Jardiance UAE, diabetes medicine Dubai, empagliflozin Saudi Arabia Riyadh, SGLT2 inhibitor Middle East supplier, diabetes tablets Qatar Kuwait
Africa
Jardiance South Africa, empagliflozin Johannesburg, Cape Town diabetes medicine, Jardiance Nigeria supplier, Kenya diabetes treatment medicine
Asia-Pacific
Jardiance Australia, empagliflozin Singapore supplier, diabetes medicine India export, SGLT2 inhibitor Asia Pacific
Latin America
Jardiance Brazil, empagliflozin Mexico pharmacy, diabetes medicine Chile supplier, Argentina SGLT2 inhibitor
